相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY
Simon D. Harding et al.
NUCLEIC ACIDS RESEARCH (2018)
The complete European guidelines on phenylketonuria: diagnosis and treatment
A. M. J. van Wegberg et al.
ORPHANET JOURNAL OF RARE DISEASES (2017)
Efficacy, safety and population pharmacokinetics of sapropterin in PKU patients < 4 years: results from the SPARK open-label, multicentre, randomized phase IIIb trial
Ania C. Muntau et al.
ORPHANET JOURNAL OF RARE DISEASES (2017)
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Enzymes
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
6R-tetrahydrobiopterin treated PKU patients below 4 years of age: Physical outcomes, nutrition and genotype
Luis Aldamiz-Echevarria et al.
MOLECULAR GENETICS AND METABOLISM (2015)
A randomized, placebo-controlled, double-blind study of sapropterin to treat ADHD symptoms and executive function impairment in children and adults with sapropterin-responsive phenylketonuria
B. Burton et al.
MOLECULAR GENETICS AND METABOLISM (2015)
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
Larissa Shamseer et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
Larissa Shamseer et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Quality of Life (QoL) assessment in a cohort of patients with Phenylketonuria
Chiara Cazzorla et al.
BMC PUBLIC HEALTH (2014)
Tetrahydrobiopterin therapy vs phenylalanine-restricted diet: Impact on growth in PKU
Luis Aldamiz-Echevarria et al.
MOLECULAR GENETICS AND METABOLISM (2013)
START, a double blind, placebo-controlled pharmacogenetic test of responsiveness to sapropterin dihydrochloride in phenylketonuria patients
Jeanine R. Jarnes Utz et al.
MOLECULAR GENETICS AND METABOLISM (2012)
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Julian P. T. Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Pathogenesis of cognitive dysfunction in phenylketonuria: Review of hypotheses
M. J. de Groot et al.
MOLECULAR GENETICS AND METABOLISM (2010)
Efficacy of Sapropterin Dihydrochloride in Increasing Phenylalanine Tolerance in Children with Phenylketonuria: A Phase III, Randomized, Double-Blind, Placebo-Controlled Study
Friedrich K. Trefz et al.
JOURNAL OF PEDIATRICS (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
Phenylalanine blood levels and clinical outcomes in phenylketonuria: A systematic literature review and meta-analysis
Susan E. Waisbren et al.
MOLECULAR GENETICS AND METABOLISM (2007)
Efficacy of sapropterin dihydrochloride (tetrahydrobiopterin, 6R-BH4) for reduction of phenylalanine concentration in patients with phenylketonuria: a phase III randomised placebo-controlled study
Harvey L. Levy et al.
LANCET (2007)
Neonatal screening in Europe; the situation in 2004
J. Gerard Loeber
JOURNAL OF INHERITED METABOLIC DISEASE (2007)
Meta-analysis of neuropsychological symptoms of adolescents and adults with PKU
J. J. Moyle et al.
NEUROPSYCHOLOGY REVIEW (2007)
Short-term dietary interventions in children and adolescents with treated phenylketonuria: Effects on neuropsychological outcome of a well-controlled population
SCJ Huijbregts et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2002)
Behaviour in early treated phenylketonuria: a systematic review
I Smith et al.
EUROPEAN JOURNAL OF PEDIATRICS (2000)
分享论文
